Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Ats Medical Inc (ATSI) since 2010 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Ats Medical Inc. Table 2 shows the detailed insider transactions. This company's CIK number is 824068.
Total stock buying since 2010: $0.
Total stock sales since 2010: $111,006.
Total stock option exercises since 2010: $0.
▪ Recent SEC 13D filings for all companies
▪ Recent portfolio reports of all companies
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2010 | 0 | $0 | 28,025 | $111,006 | 283,635 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2010-08 | 0 | $0 | 0 | $0 | 37,000 | $0 |
| 2010-07 | 0 | $0 | 14,900 | $59,018 | 60,000 | $0 |
| 2010-06 | 0 | $0 | 13,125 | $51,988 | 80,000 | $0 |
| 2010-05 | 0 | $0 | 0 | $0 | 106,635 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2010-08-11 | Swandal Craig A (Vice President of Operations) | Option Ex | 17,000 | .00 | 0 |
| 2010-08-01 | Berthe Astrid Marie (VP-Reg Affairs/Qual Assurance) | Option Ex | 10,000 | .00 | 0 |
| 2010-08-01 | Kramer Michael R (Chief Financial Officer) | Option Ex | 10,000 | .00 | 0 |
| 2010-07-30 | Coffindaffer Thaddeus (Vice President of Sales) | Option Ex | 10,000 | .00 | 0 |
| 2010-07-30 | Kramer Michael R (Chief Financial Officer) | Option Ex | 10,000 | .00 | 0 |
| 2010-07-30 | Dale Michael D (Chief Executive Officer) | Option Ex | 40,000 | .00 | 0 |
| 2010-07-01 | Berthe Astrid Marie (VP-Reg Affairs/Qual Assurance) | Sale | 14,900 | 3.96 | 59,018 |
| 2010-06-30 | Berthe Astrid Marie (VP-Reg Affairs/Qual Assurance) | Option Ex | 40,000 | .00 | 0 |
| 2010-06-30 | Elizondo David R (VP-Research & Development) | Sale | 13,125 | 3.96 | 51,988 |
| 2010-06-30 | Elizondo David R (VP-Research & Development) | Option Ex | 40,000 | .00 | 0 |
| 2010-05-12 | Skokos Theodore C (Director) | Option Ex | 21,327 | .00 | 0 |
| 2010-05-12 | Anderson Steven Michael (Director) | Option Ex | 21,327 | .00 | 0 |
| 2010-05-12 | Munzenrider Robert E (Director) | Option Ex | 21,327 | .00 | 0 |
| 2010-05-12 | Sivertson Eric W (Director) | Option Ex | 21,327 | .00 | 0 |
| 2010-05-12 | Nohra Guy P (Director) | Option Ex | 21,327 | .00 | 0 |
Insider trading activities including stock purchases, stock sales, and option exercises of ATSI listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Ats Medical Inc (symbol ATSI, CIK number 824068) see the Securities and Exchange Commission (SEC) website.